Stay updated on Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol (v2.15.0) and includes the EudraCT number for the study on Moderate to Severe Atopic Hand and Foot Dermatitis, while significant details about the study's objectives and criteria have been removed.SummaryDifference12%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.